Found: 112
Select item for more details and to access through your institution.
Increasing Incidence of Primary Malignant Brain Tumors: Influence of Diagnostic Methods.
- Published in:
- JNCI: Journal of the National Cancer Institute, 1992, v. 84, n. 6, p. 442, doi. 10.1093/jnci/84.6.442
- By:
- Publication type:
- Article
AMP‐dependent protein kinase alpha 2 isoform promotes hypoxia‐induced VEGF expression in human glioblastoma.
- Published in:
- Glia, 2006, v. 53, n. 7, p. 733, doi. 10.1002/glia.20326
- By:
- Publication type:
- Article
Rapid real‐world data analysis of patients with cancer, with and without COVID‐19, across distinct health systems.
- Published in:
- Cancer Reports, 2021, v. 4, n. 5, p. 1, doi. 10.1002/cnr2.1388
- By:
- Publication type:
- Article
The Corpus Callosum Wallerian Degeneration in the Unilateral Brain Tumors: Evaluation with Diffusion Tensor Imaging (DTI).
- Published in:
- Journal of Clinical & Diagnostic Research, 2013, v. 7, n. 2, p. 320, doi. 10.7860/JCDR/2013/4491.2757
- By:
- Publication type:
- Article
Clinical trials of R-(-)-gossypol (AT-101) in newly diagnosed and recurrent glioblastoma: NABTT 0602 and NABTT 0702.
- Published in:
- PLoS ONE, 2024, v. 19, n. 1, p. 1, doi. 10.1371/journal.pone.0291128
- By:
- Publication type:
- Article
Gliosarcoma Stem Cells Undergo Glial and Mesenchymal Differentiation In Vivo.
- Published in:
- Stem Cells, 2010, v. 28, n. 2, p. 181, doi. 10.1002/stem.264
- By:
- Publication type:
- Article
Phase 2 study of CT-322, a targeted biologic inhibitor of VEGFR-2 based on a domain of human fibronectin, in recurrent glioblastoma.
- Published in:
- Investigational New Drugs, 2015, v. 33, n. 1, p. 247, doi. 10.1007/s10637-014-0186-2
- By:
- Publication type:
- Article
Cilengitide-Induced Temporal Variations in Transvascular Transfer Parameters of Tumor Vasculature in a Rat Glioma Model: Identifying Potential MRI Biomarkers of Acute Effects.
- Published in:
- PLoS ONE, 2013, v. 8, n. 12, p. 1, doi. 10.1371/journal.pone.0084493
- By:
- Publication type:
- Article
Machine-Based Morphologic Analysis of Glioblastoma Using Whole-Slide Pathology Images Uncovers Clinically Relevant Molecular Correlates.
- Published in:
- PLoS ONE, 2013, v. 8, n. 11, p. 1, doi. 10.1371/journal.pone.0081049
- By:
- Publication type:
- Article
MicroRNA-145 Is Downregulated in Glial Tumors and Regulates Glioma Cell Migration by Targeting Connective Tissue Growth Factor.
- Published in:
- PLoS ONE, 2013, v. 8, n. 2, p. 1, doi. 10.1371/journal.pone.0054652
- By:
- Publication type:
- Article
DW-MRI as a Biomarker to Compare Therapeutic Outcomes in Radiotherapy Regimens Incorporating Temozolomide or Gemcitabine in Glioblastoma.
- Published in:
- PLoS ONE, 2012, v. 7, n. 4, p. 1, doi. 10.1371/journal.pone.0035857
- By:
- Publication type:
- Article
Prediction of Glioblastoma Multiform Response to Bevacizumab Treatment Using Multi-Parametric MRI.
- Published in:
- PLoS ONE, 2012, v. 7, n. 1, p. 1, doi. 10.1371/journal.pone.0029945
- By:
- Publication type:
- Article
Angiogenesis and apoptosis in glioma: Two arenas for promising new therapies.
- Published in:
- Journal of Cellular Biochemistry, 2005, v. 96, n. 1, p. 16, doi. 10.1002/jcb.20475
- By:
- Publication type:
- Article
Loss of genetic information in central nervous system tumors common to children and young adults.
- Published in:
- Genes, Chromosomes & Cancer, 1990, v. 2, n. 2, p. 94, doi. 10.1002/gcc.2870020204
- By:
- Publication type:
- Article
DCE-MRI prediction of survival time for patients with glioblastoma multiforme: using an adaptive neuro-fuzzy-based model and nested model selection technique.
- Published in:
- NMR in Biomedicine, 2017, v. 30, n. 9, p. n/a, doi. 10.1002/nbm.3739
- By:
- Publication type:
- Article
An extended vascular model for less biased estimation of permeability parameters in DCE-T1 images.
- Published in:
- NMR in Biomedicine, 2017, v. 30, n. 6, p. n/a, doi. 10.1002/nbm.3698
- By:
- Publication type:
- Article
A parametric model of the brain vascular system for estimation of the arterial input function (AIF) at the tissue level.
- Published in:
- NMR in Biomedicine, 2017, v. 30, n. 5, p. n/a, doi. 10.1002/nbm.3695
- By:
- Publication type:
- Article
Peritumoral tissue compression is predictive of exudate flux in a rat model of cerebral tumor: an MRI study in an embedded tumor.
- Published in:
- NMR in Biomedicine, 2015, v. 28, n. 11, p. 1557, doi. 10.1002/nbm.3418
- By:
- Publication type:
- Article
Intratumor distribution and test-retest comparisons of physiological parameters quantified by dynamic contrast-enhanced MRI in rat U251 glioma.
- Published in:
- NMR in Biomedicine, 2014, v. 27, n. 10, p. 1230, doi. 10.1002/nbm.3178
- By:
- Publication type:
- Article
Brain tumor segmentation and characterization by pattern analysis of multispectral NMR images.
- Published in:
- NMR in Biomedicine, 1998, v. 11, n. 4/5, p. 201, doi. 10.1002/(SICI)1099-1492(199806/08)11:4/5<201::AID-NBM508>3.0.CO;2-6
- By:
- Publication type:
- Article
Predicting survival in glioblastomas using diffusion tensor imaging metrics.
- Published in:
- Journal of Magnetic Resonance Imaging, 2010, v. 32, n. 4, p. 788, doi. 10.1002/jmri.22304
- By:
- Publication type:
- Article
Assessment of brain tumor angiogenesis inhibitors using perfusion magnetic resonance imaging: quality and analysis results of a phase I trial.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Phase II Clinical and Pharmacologic Study of Radiation Therapy and Carboxyamido-triazole (CAI) in Adults with Newly Diagnosed Glioblastoma Multiforme.
- Published in:
- Investigational New Drugs, 2007, v. 25, n. 3, p. 259, doi. 10.1007/s10637-006-9023-6
- By:
- Publication type:
- Article
Genetics of the malignant progression of astrocytoma.
- Published in:
- Journal of Cellular Biochemistry, 1991, v. 46, n. 1, p. 3, doi. 10.1002/jcb.240460103
- By:
- Publication type:
- Article
Comprehensive genomic characterization defines human glioblastoma genes and core pathways.
- Published in:
- Nature, 2008, v. 455, n. 7216, p. 1061, doi. 10.1038/nature07385
- By:
- Publication type:
- Article
Integrated morphologic analysis for the identification and characterization of disease subtypes.
- Published in:
- Journal of the American Medical Informatics Association, 2012, v. 19, n. 2, p. 317, doi. 10.1136/amiajnl-2011-000700
- By:
- Publication type:
- Article
Big Data Needs Big Governance: Best Practices From Brain-CODE, the Ontario-Brain Institute's Neuroinformatics Platform.
- Published in:
- Frontiers in Genetics, 2019, p. N.PAG, doi. 10.3389/fgene.2019.00191
- By:
- Publication type:
- Article
A serum-based DNA methylation assay provides accurate detection of glioma.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 9, p. 1494, doi. 10.1093/neuonc/noab023
- By:
- Publication type:
- Article
A phase II study of dose-dense temozolomide and lapatinib for recurrent low-grade and anaplastic supratentorial, infratentorial, and spinal cord ependymoma.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 3, p. 468, doi. 10.1093/neuonc/noaa240
- By:
- Publication type:
- Article
Safety and efficacy of depatuxizumab mafodotin + temozolomide in patients with EGFR-amplified, recurrent glioblastoma: results from an international phase I multicenter trial.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 1, p. 106, doi. 10.1093/neuonc/noy091
- By:
- Publication type:
- Article
ATIM-26. IMMUNOLOGIC TRENDS ASSOCIATED WITH PATIENT OUTCOMES IN A PHASE 1 CLINICAL TRIAL OF TOCA 511 AND TOCA FC IN RECURRENT HIGH GRADE GLIOMA.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi6, doi. 10.1093/neuonc/noy148.021
- By:
- Publication type:
- Article
Phase II study of cabozantinib in patients with progressive glioblastoma: subset analysis of patients with prior antiangiogenic therapy.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 2, p. 259, doi. 10.1093/neuonc/nox151
- By:
- Publication type:
- Article
Phase II study of cabozantinib in patients with progressive glioblastoma: subset analysis of patients naive to antiangiogenic therapy.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 2, p. 249, doi. 10.1093/neuonc/nox154
- By:
- Publication type:
- Article
A phase I study of cediranib in combination with cilengitide in patients with recurrent glioblastoma.
- Published in:
- Neuro-Oncology, 2015, v. 17, n. 10, p. 1386, doi. 10.1093/neuonc/nov085
- By:
- Publication type:
- Article
Two cilengitide regimens in combination with standard treatment for patients with newly diagnosed glioblastoma and unmethylated MGMT gene promoter: results of the open-label, controlled, randomized phase II CORE study.
- Published in:
- Neuro-Oncology, 2015, v. 17, n. 5, p. 708, doi. 10.1093/neuonc/nou356
- By:
- Publication type:
- Article
Clinical course and progression-free survival of adult intracranial and spinal ependymoma patients.
- Published in:
- Neuro-Oncology, 2015, v. 17, n. 3, p. 440, doi. 10.1093/neuonc/nou162
- By:
- Publication type:
- Article
Brain Malignancy Steering Committee clinical trials planning workshop: Report from the Targeted Therapies Working Group.
- Published in:
- Neuro-Oncology, 2015, v. 17, n. 2, p. 180, doi. 10.1093/neuonc/nou154
- By:
- Publication type:
- Article
THE P53 PATHWAY AND ANCESTRAL PROGENITORS ARE ASSOCIATED WITH TUMOR RECURRENCE IN GLIOBLASTOMA.
- Published in:
- Neuro-Oncology, 2014, v. 16, n. suppl_3, p. iii3, doi. 10.1093/neuonc/nou206.10
- By:
- Publication type:
- Article
CABOZANTINIB IS EFFECTIVE IN A SUBSET OF XENOGRAFT GBM TUMORS AND AFFECTS MULTIPLE SIGNALING PATHWAYS.
- Published in:
- Neuro-Oncology, 2014, v. 16, n. suppl_3, p. iii38, doi. 10.1093/neuonc/nou208.58
- By:
- Publication type:
- Article
BRAIN TUMOR CARE THROUGH THE PATIENT'S EYES — THE VALUE OF A COMPREHENSIVE BRAIN TUMOR CENTER.
- Published in:
- Neuro-Oncology, 2014, v. 16, n. suppl_3, p. iii50, doi. 10.1093/neuonc/nou209.31
- By:
- Publication type:
- Article
NABTT 0502: a phase II and pharmacokinetic study of erlotinib and sorafenib for patients with progressive or recurrent glioblastoma multiforme.
- Published in:
- Neuro-Oncology, 2013, v. 15, n. 4, p. 490, doi. 10.1093/neuonc/nos322
- By:
- Publication type:
- Article
Phase I study of terameprocol in patients with recurrent high-grade glioma.
- Published in:
- Neuro-Oncology, 2012, v. 14, n. 4, p. 511
- By:
- Publication type:
- Article
Differentiating treatment-induced necrosis from recurrent/progressive brain tumor using nonmodel-based semiquantitative indices derived from dynamic contrast-enhanced T1-weighted MR perfusion.
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 9, p. 1037, doi. 10.1093/neuonc/nor075
- By:
- Publication type:
- Article
Cilengitide induces autophagy-mediated cell death in glioma cells.
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 8, p. 857, doi. 10.1093/neuonc/nor073
- By:
- Publication type:
- Article
Neurocognitive function in patients with recurrent glioblastoma treated with bevacizumab.
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 6, p. 660, doi. 10.1093/neuonc/nor024
- By:
- Publication type:
- Article
CNS Cancer Models.
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 2, p. 261, doi. 10.1093/neuonc/noq186
- By:
- Publication type:
- Article
Response as a predictor of survival in patients with recurrent glioblastoma treated with bevacizumab.
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 1, p. 143, doi. 10.1093/neuonc/noq151
- By:
- Publication type:
- Article
Polynuclear platinum anticancer drugs are more potent than cisplatin and induce cell cycle arrest in glioma.
- Published in:
- Neuro-Oncology, 2006, v. 8, n. 3, p. 215, doi. 10.1215/15228517-2006-004
- By:
- Publication type:
- Article
Phase 2 trial of copper depletion and penicillamine as antiangiogenesis therapy of glioblastoma.
- Published in:
- Neuro-Oncology, 2005, v. 7, n. 3, p. 246, doi. 10.1215/S1152851704000869
- By:
- Publication type:
- Article
Phase 2 study of weekly irinotecan in adults with recurrent malignant glioma: Final report of NABTT 97-11.
- Published in:
- Neuro-Oncology, 2004, v. 6, n. 1, p. 21, doi. 10.1215/S1152851703000218
- By:
- Publication type:
- Article